Baseline moderate-range albuminuria is associated with protection against severe COVID-19 pneumonia

doi:10.4239/wjd.v13.i12.1154

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3108)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

176

WORD

HTML

1395

Figures (1-2)

281

Tables (1-5)

293

Sum=2167

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

271

Download

670

Sum=941

Dec 15, 2022 (publication date) through Jan 8, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Diabetes. Dec 15, 2022; 13(12): 1154-1167
Published online Dec 15, 2022. doi: 10.4239/wjd.v13.i12.1154

Full Size Figure Download Figure

Figure 1 Enrolled participants and analysis groups. COVID-19: Coronavirus disease 2019.

Citation: Bashkin A, Shehadeh M, Shbita L, Namoura K, Haiek R, Kuyantseva E, Boulos Y, Yakir O, Kruzel-Davila E. Baseline moderate-range albuminuria is associated with protection against severe COVID-19 pneumonia. World J Diabetes 2022; 13(12): 1154-1167
URL: https://www.wjgnet.com/1948-9358/full/v13/i12/1154.htm
DOI: https://dx.doi.org/10.4239/wjd.v13.i12.1154